1 / 22

OHRP Update

OHRP Update. Ivor Pritchard, Ph.D. Senior Advisor to the Director of OHRP Ivor.Pritchard@hhs.gov April 26, 2014. La connexion historique entre Montréal et Washington. Upcoming Events. Internet Research Webinar (May 8 and following) Research Community Fora: Cincinnati, Ohio: May 21

amina
Télécharger la présentation

OHRP Update

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. OHRP Update Ivor Pritchard, Ph.D. Senior Advisor to the Director of OHRP Ivor.Pritchard@hhs.gov April 26, 2014

  2. La connexion historique entre Montréal et Washington

  3. Upcoming Events Internet Research Webinar (May 8 and following) Research Community Fora: • Cincinnati, Ohio: May 21 • Seattle, Washington: July 31 • Philadelphia, Pennsylvania: October 23-24

  4. Secretary’s Advisory Committee on Human Research Protections • Internet Research • Randomized Cluster Trials • Engagement in Research • Big Data Research and Protections (TBD) • Informed Consent (TBD)

  5. Ongoing Activities • Follow-up to the SUPPORT Trial compliance determination and subsequent controversy • Follow-up to the Advance Notice of Proposed Rulemaking (ANPRM), “Human Subjects Research Protections: Enhancing Protections for Research Subjects and Reducing Burden, Delay, and Ambiguity for Investigators”(July, 2011)

  6. Should the Regulations be Changed? • The Common Rule got it wrong, and it’s time to change it. • The Common Rule no longer suits the research enterprise well, and so it should be changed.

  7. Changes in Life Expectancy (U.S.A.) 1900: 49 1950: 68 1971: 72 1991: 75 2008: 78

  8. Changes in Leading Causes/Rates of Death (USA:rank/deaths per 100,000)

  9. Changes in Technology

  10. Changes in Research Technology

  11. Changes in the Research/Practice Relationship: Institutions • Patient-Centered Outcomes Research Institute (2010) • The National Center for Advancing Translational Sciences (2011) • The National Institutes of Health (NIH) NIH Collaboratory (2012)

  12. Changes in the Research/Practice Relationship: Research Design • Comparative Effectiveness Research • Randomized Cluster Trials • Pragmatic Clinical Trials • Community-Based Participatory Action Research

  13. Changes in Law/Regulation? A Case Example “A well-regulated militia being necessary to the security of a free state, the right of the people to keep and bear arms shall not be infringed.” (1791)

  14. How should the regulations be changed? The regulations could be changed in numerous ways, some for the better, some for the worse.

  15. A Proposal for Change Human Subjects Research Protections: Enhancing Protections for Research Subjects and Reducing Burden, Delay, and Ambiguity for Investigators (Advance Notice of Proposed Rulemaking (ANPRM), July, 2011)

  16. ANPRM Proposals • Scope of regulatory jurisdiction • Single IRB review for domestic multi-site studies • Informed Consent improvements • Single set of security/confidentiality standards • Data Reporting • Uniformity of regulatory guidance • Biospecimen research • Revised tiers of review

  17. Simple vs. Complex

  18. Simple vs. Complex • Single IRB review for domestic multi-site studies Simple • Informed Consent improvements Simple • Single set of security/confidentiality standards Simple • Data Reporting Simple • Uniformity of regulatory guidance Simple • Biospecimen research Complex • Revised tiers of review Complex

  19. Convened Board No review Review Requirements Under the 1991Common Rule Expedited

  20. Review Tailored to be Commensurate with Risks • Single or Multiple Review? • Convened or Expedited Review? • Continuing Review or Not? • Biospecimen Research? • Excused so long as conditions are met? • No Review?

  21. Using the Right Bucket

  22. Who will carry the water?

More Related